In this interview Robert Harington asks Daniel Hook (CEO of Digital Science and co-author of the new Digital Science report. How COVID-19 is Changing Research Culture) about his views on fundamental shifts in research culture as a result of the COVID-19 global pandemic.

Systemic racism, sexual harassment and institutional bias permeate a film about three female scientists, who have survived and thrived.

The pressure on researchers from ethnic minority groups to participate in campus diversity issues comes at a cost.

One interesting and unintended consequence of the current pandemic has been an increase in people’s engagement with citizen science. 

Pandemic politics highlight how predictions need to be transparent and humble to invite insight, not blame.

Race matters for quotas and funding -- but please don't be Black (and loud) when it matters: A guest article by Lauren Edwards, Neuroscientist.

Why aren't more administrators who say they support diversity, equity and inclusion initiatives reaching out to their black colleagues now?

College leaders seeking to survive and thrive in a post-pandemic environment have no choice but to reassess and redefine their value proposition, argue professors.

Universities are facing a severe financial crisis and some contract staff are hanging by a thread. Senior colleagues need to speak up now.

It is likely we'll eventually have a coronavirus vaccine - but perhaps not as quickly as some expect. From development, to clinical trials and distribution, ProPublica reporter Caroline Chen explains the tremendous challenges that lie ahead.

This Article examines the effect of abolishing peer review on the changed incentive structure and the likely effects on the behaviour of individual scientists, and concludes that, abolishing peer review has overall slightly positive results.

Two major study retractions in one month have left researchers wondering if the peer review process is broken.

Richard Horton does not hold back in his criticism of the UK's response to the pandemic and the medical establishment's part in backing fatal government decisions.

Nations are increasingly making conscious efforts to propel a subset of their universities into the global elite. But are such aspirations ever met? And, if they are, is that a blessing or a curse for those institutions denied entry to the club?

COVID-19 has given the public a newfound sense of the vitality of science. At the same time, policy makers are more than ever leaning on scientific advice to guide the way forward.

Plenty of scientists are resentful of demands to recognise the need for diversity in science.

Ignoring science's legacy of racism or a wider culture shaped by white supremacy doesn't make scientists "objective".

It is easy to make excuses – the legacy of historic racism is so strong that there are not a lot of senior Black scientists to choose from, and those that have survived the gauntlet are in demand and overcommitted, and so on and so forth. But these excuses are lame.

Despite the special calls for research into the novel coronavirus, researchers should all still concentrate on what they do best, writes Matthias Egger, President of the National Research Council of the SNSF.

The now retracted paper halted hydroxychloroquine trials. Studies like this determine how people live or die tomorrow.

Acknowledge the history. Revise your work. Refuse to be complicit.

Restaurants get eulogies. Airlines get bailouts. Shakespeare gets kicked when he's down.

Humanities Research Infrastructure is critical social investment, and we could support it better if we understood it better.

Learned societies face many new challenges in the face of a pandemic.

Concerns 50 years of progress could be put into reverse unless government intervenes.

Possibly the only thing spreading faster than COVID-19 is the pseudoscience about COVID-19.

The Cummings saga has made it plain that scientific advisers are shielding the government's collapsing reputation on coronavirus, says Lancet editor Richard Horton.

Data sharing has not changed, but the pandemic highlights not only how important data sharing is (like other crises have, for instance, the climate crisis) but how it spotlights larger issues in our data sharing social and technical infrastructure.

As the world attempts to cope with the devastating impact of the COVID-19 pandemic, researchers about to start PhDs and postdocs face particular challenges.

It looks as though preprints are here to stay in biomedicine - but are there too many of them?